Autocrine ligands of the epithelial growth factor receptor mediate inflammatory responses to diesel exhaust particles by Parnia, Sam et al.
Parnia et al. Respiratory Research 2014, 15:22
http://respiratory-research.com/content/15/1/22RESEARCH Open AccessAutocrine ligands of the epithelial growth factor
receptor mediate inflammatory responses
to diesel exhaust particles
Sam Parnia1, Lynnsey M Hamilton1, Sarah M Puddicombe1, Stephen T Holgate1, Anthony J Frew1
and Donna E Davies1,2*Abstract
Background: Diesel exhaust is associated with cardiovascular and respiratory mortality and morbidity. Acute
exposure leads to increased IL-8 expression and airway neutrophilia, however the mechanism of this response is
unknown. Objectives: As cigarette smoke-induced IL-8 expression by epithelial cells involves transactivation of the
epidermal growth factor receptor (EGFR), we studied the effects of diesel exhaust particles (DEP) on IL-8 release and
the role of the EGFR.
Methods: Primary bronchial epithelial cells (PBEC) were exposed to DEPs or carbon black. IL-8 and EGFR ligand
expression (transforming growth factor alpha (TGFα), heparin-binding EGF-like growth factor, and amphiregulin
(AR)) were assessed by quantitative RT-PCR and ELISA.
Results: DEP, but not carbon black, caused a dose-dependent increase in mitogen-activated protein kinase (MAPK)
activation and IL-8 expression, however above 50 μg/ml there was an increase in cytotoxicity. At 50 μg/ml, DEPs
stimulated transcription and release of IL-8 and EGFR ligands. IL-8 release was blocked by EGFR neutralizing
antibodies, an EGFR-selective tyrosine kinase inhibitor and by the metalloprotease inhibitor, GM6001, which blocks
EGFR ligand shedding. Neutralizing antibodies to AR, TGFα and heparin-binding (HB)-EGF reduced DEP-induced IL-8
by >50%. Conclusion Expression of IL-8 in response to DEPs is dependent on EGFR activation and that autocrine
production of EGFR ligands makes a substantial contribution to this response. Capsule Summary: This study identifies
a mechanism whereby diesel particles stimulates IL-8 release from bronchial epithelial cells. This mechanism may
help to explain the recruitment of neutrophils into the airways of people exposed to particulate air pollution.
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Ligand sheddingIntroduction
Diesel exhaust particles (DEPs) are now one of the major
contributors to inhalable particulate matter pollution
throughout the industrialized world. Although several epi-
demiological studies have reported associations between
daily concentrations of ambient particulate matter (PM)
and increased incidences of allergies, asthma, respiratory
infections, increased hospitalization for respiratory diseases,* Correspondence: donnad@soton.ac.uk
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reproduction in any medium, provided the ordecreased pulmonary function, and premature mortality
among the general population [1,2], the mechanisms lead-
ing to disease have not been fully elucidated.
The mechanism by which DEPs induce their effects is
complex and relates to both the physical and chemical
properties of the particles. The chemical properties of
the particles involved in inflammatory responses are
thought to be due to a combination of oxidative stress
and the effects arising from the organic fraction of the
particles. This is especially complex, as DEPs contain
hundreds (or even thousands) of compounds including
poly aromatic hydrocarbons, which are known human
carcinogens [3].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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unteers [5], exposure to DEPs causes airway neutrophilia.
In vitro studies have demonstrated that exposure to DEPs
leads to an inflammatory response as demonstrated by an
increase in the release of Interleukin-8 (IL-8, CXCL8),
Monocyte Chemotactic Protein 1 (MCP1, CCL2) and Reg-
ulated Upon Activation, Normally T-Expressed, And Pre-
sumably Secreted (RANTES, CCL5) as well as soluble
Intercellular Adhesion Molecule 1 (ICAM-1) [6-8]. DEPs
activate the p38 mitogen-activated protein (MAP) kinase
pathway which leads to the production of IL-8 and
RANTES by human bronchial epithelial cells (HBEC) [9].
IL-8 is a potent neutrophil chemoattractant and is pro-
duced by bronchial epithelial cells in response to oxidants
via activation of nuclear factor kappa B (NFκB) [10]. Many
inhaled substances such as cigarette smoke extract (CSE)
and DEPs contain oxidants that may play an important
role in the recruitment and activation of neutrophils
in vivo. However studies have demonstrated that the re-
lease of this inflammatory mediator in response to CSE
also involves other mechanisms, including activation of
the Epidermal Growth Factor Receptor (EGFR) [11].
The EGFR is one of the major receptors expressed by
epithelial cells and its expression is increased both in
asthma [12] and in chronic smokers [13]. Bronchial epithe-
lial cells also produce ligands for the EGFR, which include
transforming growth factor α (TGFα) heparin-binding
EGF-like growth factor (HB-EGF) and amphiregulin (AR)
[14]. These growth factors are produced as transmembrane
precursor molecules whose processing and release (ectodo-
main shedding) is a highly regulated process involving
metalloproteinases [15], and functionally contribute to
epithelial maintenance and repair. HB-EGF shedding has
been associated with transactivation of the EGFR by G-
protein coupled receptors [16]. EGF is known to stimulate
IL-8 production by primary bronchial epithelial cells [17]
and in studies using CSE, we have demonstrated that
secretion of IL-8 is partially dependent on EGFR activation
via autocrine ligand shedding [11]. As we have demon-
strated that in vivo exposure to DEPs causes EGFR activa-
tion [18] and induction of IL-8 in the bronchial epithelium
[19], we investigated the involvement of autocrine ligands
in the release of IL-8 from bronchial epithelial cells
in response to DEP. Here we show that DEPs is able
to induce expression and release of EGFR ligands
and that synthesis and release of IL-8 in response
to DEP is dependent on EGFR activation by these
ligands.
Materials and methods
Carbon Black (CB) (PM 2.5) was donated by Dr Kelly
Berube (University of Cardiff ). These particles had been
originally obtained from Monarch 880CB (Cabot, Billerica,
MA). DEP was purchased from the NIST (NationalInstitute of Standards & Technology, Gaithersburg, MD,
USA). DEP stocks were prepared as suspensions in Ultra-
culture serum free medium (BioWhittaker, Wokingham,
UK) at a concentration of 1mg/ml; the suspension was vor-
texed for 2 minutes before being placed in a sonic water
bath for 3 minutes. CB stocks were also prepared in the
same manner. DEP was used in the following doses (10,
50, 100, 200 μg/ml). CB was used at 200 μg/ml) The neu-
tralizing polyclonal sheep anti-EGFR antibody was raised
against EGF affinity-purified receptors derived from A431
squamous carcinoma cell membranes [20] and was partially
purified by (NH4)2SO4 precipitation and diethylaminoethyl
(DE-52; Whatman, Maidstone, Kent, UK) ion exchange
chromatography [11]. The EGFR-selective tyrosine kinase
inhibitor, AG1478 (Biomol Research Laboratories Inc.,
Plymouth Meeting, PA) and the broad metalloproteinase
inhibitor, GM6001 (Chemicon, International, Temecula,
CA 92590) were prepared as stock solutions in (dimethyl
sulphoxide) DMSO and diluted in medium for use; vehicle
controls were performed. Neutralizing antibodies to Amphi-
regulin, HB-EGF and TGFα were purchased from R & D
Systems (Abingdon, Oxford, UK). The doses used were
based on our prior experience with bronchial epithelial cells
cultures [11]. All measurements were carried out at 6 hour
intervals up to 24 hours for all experiments described below
aside from the western blot which was carried out at 10, 30
and 60 minute intervals.
Fiberoptic bronchoscopy and primary bronchial epithelial
cell cultures
Bronchial epithelial brushings were obtained by fibreoptic
bronchoscopy from non-smoking adult volunteers (N =
10, five males, five females), mean age 34.7 years (range
22–54) and mean FEV1 105.7% (range 95–120%) pre-
dicted. All subjects were free from respiratory tract infec-
tions for a minimum of 4 weeks before the study. Written
informed consent was obtained from all volunteers and
ethical approval was obtained from the Joint Ethics Com-
mittee of Southampton University and General Hospital.
Bronchoscopy was performed using a fiberoptic broncho-
scope (FB-20D; Olympus, Tokyo, Japan) in accordance
with standard published guidelines [21]. Epithelial cells
were obtained using a standard sterile single-sheathed
nylon cytology brush. The cells were cultured in Bronchial
Epithelial Growth Medium (BEGM) (Clonetics, San Diego,
CA) in flasks coated with collagen using Vitrogen-100
(Nutacon, Leimuiden, The Netherlands), as previously de-
scribed [22]. The epithelial cells were grown as monolayer
cultures in BEGM, seeded into 24-well culture trays and
used for assays at passage two.
The cells were exposed to BEGM±DEPs in the pres-
ence or absence of 1 μM AG1478, 1 μM GM6001, (a
broad MMP Inhibitor), 500 μg/ml sheep anti-EGFR anti-
body, neutralizing antibody to HB-EGF (4 μg/ml), AR
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CO2. The conditioned medium was then removed from
the cells, clarified by centrifugation, and stored at -80°C
until assay. The cells were taken for RNA extraction
(see below).
Lactate dehydrogenase (LDH) assay
The proliferation of primary bronchial epithelial cells
(PBECs) was measured as cell number which was deter-
mined using the methylene blue uptake assay [23] where
A630nm was shown to be proportional to cell number.
Cytotoxicity of DEP towards PBECs was determined by
monitoring the release of LDH into the cell culture
medium. An LDH activity assay kit (Sigma Aldrich, St
Louis, USA) was used, which utilizes a colorimetric
method for the detection of LDH activity and its ability
to catalyse the following reversible reaction: Pyruvic
Acid + NADH ←——→ Lactic Acid + NAD. The reac-
tion equilibrium strongly favours reduction of pyruvate
to lactate at a rate proportional to the amount of LDH.
Lactic acid, NAD and NADH do not absorb significantly
in this range. Therefore it is possible to accurately meas-
ure changes resulting from the conversion of pyruvic
acid to lactic acid due to LDH activity. A calibration
curve for serum LDH using known amounts of pyruvate,
(corresponding to a specific amounts of LDH activity)
was constructed. One vial of NADH was made up in 1
ml of sodium pyruvate, which gives 0.75 mM sodium
pyruvate and 1.28 μM NADH. This solution was used
immediately due to its unstable nature. The assay was
performed by placing 100 μl of substrate solution into 1
ml disposable cuvettes. 10 μl of assay sample (cell super-
natant) was added to each cuvette and the solution incu-
bated at 37°C for 30 minutes. After this time, 100 μl of
colour reagent was added and the cuvettes were incu-
bated at room temperature for 20 minutes. The reaction
was stopped with 1 ml 0.4 M NaOH (0.8 g in 50 mls dis-
tilled water). Absorbance was read at 450 nm using a
spectrophotometer.
The methylene blue assay
The methylene blue assay is a colorimetric method that al-
lows estimation of the number of adherent cells present in
a microculture and relies on the fact that Methylene Blue
is a basic dye that is positively charged at pH 8.5 and binds
electrostatically to negatively charged groups within cells
(predominately phosphate moieties of nucleic acids and
some charged groups in proteins). The medium was re-
moved from the cells which were then fixed with 500 μl/
well/10% Formol Saline (9 g NaCl in 100 ml 40% Formal-
dehyde and 900 ml of Water) for at least 60 minutes. After
fixation the plates were washed in running water and then
blotted dry. The wells were then stained with 250 μl of 1%
w/v Methylene Blue in 0.01 M borate buffer (3.82 gDisodiumtetraborate together with 1% Distilled water) for
30 minutes and then washed with 0.01 M Borate Buffer or
running water until no more blue dye was detected in the
washing solution, and were then blot dried. The Methy-
lene Blue in the wells was then eluted using 200 μl/well 1:1
(Volume/Volume) ETOH and 0.1 M HCL for each of the
wells in the 24 well plate. The eluted methylene blue solu-
tion was diluted (1:20) in 1:1 (V/V) ETOH and 0.1 M HCL
and made into a final volume of 100 μl in 24 wells of a 96
well plate before being read at A630 using an ELISA plate
reader.
Analysis of gene expression
RNA was extracted using TRIZOL® reagent (Invitrogen,
Paisley, UK) according to the manufacturer’s protocol.
Total RNA was DNase treated and reverse transcribed
using random hexamer primers and AMV reverse tran-
scriptase (RT) (Promega, southampton, UK). The target
primer and the probe sequences were as follows:
AR: (forward) gtggtgctgtcgctcttgatac, (reverse) gcttccca
gagtaggtgtcattg, (probe) tccaatccagcagcataatggcctga;
HB-EGF (forward) gatctggaccttttgagagtcactt, (reverse) tccc
gtgctcctccttgtt, (probe) agccacaagcactggccacacca;
TGF- (forward) ctagttggttctgggctttgatct, (reverse) tggt
tttgggcatttgagtca, (probe) ttccaacctgcccagtcacagaagg;
IL-8 (forward) aaggaaccatctcactgtgtgtaaac, (reverse) ttag
cactccttggcaaaactg, (probe) ctgccaagagagccacggccag
Each sample was assayed in duplicate using 18S rRNA
(primers and probe from Applied Biosystems) for nor-
malization. Relative gene expression was determined
using the ΔΔCt Method.
Western blotting
PBECs were exposed to DEPs for the times specified and
cell lysates prepared for western blot analysis. Samples
were subjected to SDS PAGE and Western blotting for
activated MAPK using a pan MAPK for normalization,
as previously described [12].
Analysis of growth factor and cytokine release
Enzyme-linked immunosorbent assay (ELISA) kits for
TGF-α (CN Biosciences, Nottingham, UK.), AR (R&D
Systems, Abingdon, UK), and IL-8 (Biosource Inter-
national, Camarillo, CA) were used according to the man-
ufacturer’s instructions; the minimum detectable amount
of each factor in these assays was 10, 15, and 15 pg/ml,
respectively.
Statistical analysis
Continuous data were expressed as the median and inter-
quartile range (IQR). Further analysis was carried out
using a Kruskal Wallis test followed by a Wilcoxon Signed
Ranked test using SPSS software (SPSS Inc., Chicago, IL).
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Results
IL-8 gene expression and release
After 18 h exposure to DEPs at 50 or 200 μg/ml (DEP50
or DEP200) there was significant induction of IL-8 gene
expression in PBECs (Figure 1A). This response was
equivalent to 80 ±10% of IL-8 gene expression obtained
with TNF-α (10ng/ml) (data not shown). IL-8 protein re-
lease at 24 h was also significantly enhanced in responseFigure 1 The effect of DEP on IL-8 mRNA expression (A) and
IL-8 protein release (B) by PBECs exposed to DEP in SFM for
18 h and 24 h respectively. Samples were compared with PBECs
cultured in SFM alone. Statistical analysis was carried out using
Kruskal Wallis followed by Wilcoxon signed rank test; * p < 0.01
** p < 0.005 (n = 10). (C) a typical western blot obtained after analysis of
activation of the MAPK pathway in PBEC samples exposed to 10, 50 or
200 μg/ml DEP for the times indicated. Data are representative of 4
individual experiments.to DEP exposure and was equivalent to 64 ± 5 % of IL-8
release obtained with TNFα (10 ng/ml). Carbon black (CB)
(200 μg/ml) did not induce IL-8 gene expression (relative
gene expression (median (IQR)): SFM= 1.3 (0.5-2.0) versus
CB 200 μg/ml = 1.5 (0.8-1.6) (p > 0.05), nor did it affect
basal IL-8 release (IL-8 ng/ml (median (IQR)): SFM= 2.2
(1.0-7.0) versus CB= 2.0 (1.0-3.2) p > 0.05), suggesting that
the inflammatory effects of DEPs as measured by the re-
lease of IL-8, are due to the adsorbed substances on the
surface of the particles, rather than the carbon core. Al-
though DEPs can mediate some of their effects via oxida-
tive stress [24], neither glutathione (10 μM) nor vitamin C
(250 μM) significantly affected DEPs stimulated IL-8 re-
lease (105 ± 36% and 96 ± 34% respectively, p > 0.05, n = 4).
However, in acute stimulation experiments, DEP50 caused
a transient dose-dependent increase in activation of the
MAPK pathway, with peak stimulation occurring 10 mi-
nutes after DEPs exposure (Figure 1C).Cell viability following exposure to DEP
Exposure of PBEC to DEPs for 24 h elicited a dose
dependent increase in LDH reaching significance at con-
centrations greater than 50 μg/ml (Figure 2). Carbon
black did not lead to an increase in LDH release above
control (SFM = 4 (3.8-4.2) versus CB 200 μg/ml = 4.5
(4.2-5.1) % LDH release, p > 0.05), indicating that the
toxic effects of DEPs as measured by LDH release are
due to the adsorbed substances on the surface of the
particles, rather than the carbon core. As exposure of
PBECs to doses of DEPs up to 50 μg/ml did not signifi-
cantly affect cell viability, this dose was chosen for stud-
ies of the mechanisms of DEPs-induced IL-8 production.Figure 2 PBEC viability following 24 h exposure to DEP. LDH
release was used as a measure of DEP-induced cytotoxicity and was
expressed relative to total cellular LDH. * p < 0.001 (n = 10).
Figure 3 IL-8 release from PBEC treated with DEP 50 μg/ml in
the absence or presence of EGFR inhibitors. PBEC were exposed
for 24 h to DEP50 alone or in the presence of 1 μM AG1478 (A), EGFR
neutralising antibody (EGFRAb) (500 μg/ml) (B) or 1μM GM6001 (C).
* p < 0.05 ** p < 0.01 (n = 10) compared with SFM control.
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Since we have previously demonstrated that secretion of
IL-8 in response to cigarette smoke extract involves
EGFR activation via autocrine ligand shedding [11], we
next evaluated the role of the EGFR in DEP-stimulated
IL-8 expression. When primary bronchial cells were ex-
posed to DEP50 in the presence of an EGFR-selective
tyrosine kinase inhibitor, AG1478, IL-8 release was sig-
nificantly reduced (Figure 3A). Application of neutraliz-
ing antibodies for the EGFR also significantly reduced
DEP50-induced IL-8 release (Figure 3B), indicating that
activation of the EGFR had taken place through ligand
binding to the receptor. As many agents activate the
EGFR through release of autocrine ligands, we next in-
vestigated whether ligand shedding was associated with
DEPs-induced EGFR activation. Thus, when PBEC were
pre-treated with the broad metalloproteinase inhibitor
(GM6001) IL-8 release was also reduced (Figure 3C) sug-
gesting that IL-8 release was dependent on proteolytic
cleavage of membrane bound EGFR agonists.
Involvement of autocrine ligands
To further investigate the involvement of EGFR ligands
in DEPs-stimulated IL-8 release from PBEC, we focused
on three of the major EGFR ligands expressed by epithe-
lial cells: TGFα, AR and HB-EGF. It has been demon-
strated that AR plays a major role in DEPs induced
GM-CSF release in a bronchial epithelial cell line [25].
Therefore we first investigated the effect of DEP50 on
AR gene expression and release. In contrast with the
previous study [25], we failed to observe significant
induction of AR mRNA expression at 6 or 18 h (Table 1).
However, despite a lack of mRNA induction, enhanced
secretion of AR was detected in the culture medium
of DEPs-exposed cells at 24 h (Figure 4) suggesting that
accumulation of AR is mainly due to increased shedding
rather than increased mRNA expression. In order to
further investigate the relationship between AR shedding
of and IL-8 release, we examined the effect of GM6001,
EGFR-neutralizing antibodies and AG1478. This showed
that the increase in AR release in response to DEP50
were reduced (Figure 4A) by GM6001 indicating that
the increased levels of AR in PBEC culture superna-
tants is due to proteolytic shedding from the mem-
brane. Blockade of the EGFR using a neutralizing
antibody also led to a modest but statistically signifi-
cant reduction of AR levels (Figure 4B). Inhibition
of EGFR phosphorylation using AG1478 led to a sig-
nificant reduction of AR (Figure 4C), indicating that
activation of the EGFR is needed for sustained AR
release.
As well as studying the involvement of AR in DEP-
stimulated IL-8 release, we also investigated the contri-
bution of TGF-α and HB-EGF. As for AR, levels of HB-
Table 1 The effect of DEP50 on median EGFR ligand
gene expression
AR median
(IQR)
HB-EGF
median (IQR)
TGFα
median (IQR)
SFM 2.8 (1.5-3.2) 2.0 (1.8-2.4) 2.2 (1.8–3.1)
DEP 6 h 4.1 (1.1-9.2) 4.1 (2.6-5.2) 1.5 (1.3–7.1)
DEP 18 h 2.2 (1.2-3.2) 2.0 (1.8-5.8) 4.0 (1.8–5.9)*
PBECs were exposed to DEP 50 μg/ml for 6 or 18 h and mRNA levels of the
EGFR ligands determined by RT-qPCR. *p < 0.05, n = 10.
Figure 4 The effect of DEP on AR protein expression in PBEC.
PBEC were exposed to DEP 50 μg/ml for 24 h in the absence or
presence of GM6001 (A), an EGFR neutralising antibody (EGFRAb) (B)
and AG1478 (C). AR release into the medium was measured by
ELISA. p < 0.05 ** p < 0.01 n = [10] compared with SFM.
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in the presence of DEP (Table 1); HB-EGF protein levels
could not be measured due to a lack of suitable anti-
bodies for ELISA. TGF-α expression was not signifi-
cantly increased at 6h but did increase significantly 18 h
after stimulation with DEP50 (Table 1). Consistent with
the DEP-induced increases in mRNA there was also
an increase in TGF-α release at 24 h, as measured
by ELISA (Figure 5). Release of TGF-α in response to
DEP50 was significantly reduced by GM6001 (Figure 5A),
indicating that the increased TGF-α was also due
to shedding of pro-TGF-α from the epithelial cell
membrane. In contrast with its effect on AR accu-
mulation, the EGFR antibody caused a significant
increase in TGF-α accumulation (Figure 5B). These
data suggest that the EGFR-neutralizing antibody
prevents ligand binding and internalization of the
receptor-bound ligand whereas in the absence of
the antibody, TGF-α is rapidly utilized by the cells.
Inhibition of EGFR phosphorylation using AG1478
led to a highly significant reduction in TGFα levels
(Figure 5C), as was observed for AR.
In order to determine the relative contribution of each
of the three EGFR ligands to the release of IL-8, specific
neutralizing antibodies were tested. This demonstrated
that the release of IL-8 involved all three EGFR ligands.
AR was the predominant ligand, mediating approxi-
mately 37% of the IL-8 response, whereas HB-EGF and
TGF-α mediated approximately 18-24% each (Figure 6).
In combination, the antibodies blocked DEP50-stimu-
lated IL-8 release, consistent with the suppression of IL-
8 release observed in the presence of EGFR neutralizing
antibodies or the AG1478 EGFR-selective tyrosine kin-
ase inhibitor.
Discussion
Short term in vivo exposure to DEPs induces a marked
leukocytic infiltration in the airways of healthy human
volunteers involving neutrophils, lymphocytes and mast
cells [5], which is associated with enhanced expression
of IL-8 [19]. Although, the production of IL-8 by bron-
chial epithelial cells in response to DEPs is well recog-
nized, no studies had previously explored the EGFR as a
mediator of DEP-induced IL-8 release in primary hu-
Figure 5 The effect of DEP on TGF-α protein expression in
PBEC. PBEC were exposed to DEP 50 μg/ml for 24 h in the absence
or presence of GM6001 (A), an EGFR neutralising antibody (EGFRAb)
(B) and AG1478 (C). AR release into the medium was measured by
ELISA. * P<0.01 ** P<0.005 n=(10) compared with SFM control.
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DEPs induces the expression and release of the EGFR
ligand TGF-α, as well as the release of AR and that neu-
tralizing antibodies block DEP-induced IL-8 release indi-
cates a novel, causal relationship between autocrine
EGFR ligand release and IL-8 production in response to
DEPs. These findings also suggest that this effect is due
to activation of metalloproteinases, possibly in response
to adsorbed substances, found on the surface of DEPs.
Therefore the effect of DEPs on EGFR ligand processing
and gene expression probably explains their ability to in-
duce a pro-inflammatory response.
A previous study [25] demonstrated that in a human
bronchial epithelial cell line (16HBE 14o-), DEPs and par-
ticulate matter <2.5 μm led to AR secretion through the
activation of the EGFR and Erk (extracellular signal-
regulated kinases) MAP kinase pathway by EGFR transac-
tivation via oxidative stress. AR was also demonstrated to
induce granulocyte macrophage-colony-stimulating factor
(GM-CSF) release in this study, although the in vivo rele-
vance of this remains to be established, as induction of
GM-CSF expression following acute exposure to DEPs
was not observed in a previous in vivo study [19]. In our
studies using primary bronchial epithelial cells, we foundFigure 6 The effect of AR, HB-EGF, and TGF-α neutralising
antibodies on DEP induced IL-8 release. The relative release of
IL-8 from PBECs after exposure to DEP 50 μg/ml for 24 h in the
absence or presence of TGFα, HB-EGF or AR neutralising antibodies
was determined. Data show mean ± SD (n = 3). SFM = serum free
medium, D50 = DEP 50 μg/ml, DTGFab = D50 + antibody to TGF-α,
DARab = D50 + antibody to AR, DHBEGFab = D50 + antibody to HB-EGF,
DTGF = D50 + antibody to all three ligands (TGF-α, AR, HB-EGF).
Parnia et al. Respiratory Research 2014, 15:22 Page 8 of 10
http://respiratory-research.com/content/15/1/22many similarities with the previous in vitro study [25], in-
cluding Erk activation, there were also notable differences.
Thus, the effect of the DEPs in our study was not linked
to oxidative stress. This was not surprising as the DEPs
that we studied were not freshly generated and are more
likely to represent ambient environmental particles rather
than those inhaled when in heavy traffic. DEPs are not a
single fixed particle type but their composition and hence
biological activity may vary depending on many factors in-
cluding the fuel source, other environmental factors in-
cluding pollutants and allergens as well as time elapsed
since combustion [26,27]. There may also be some differ-
ences between ‘fresh’ DEPs, which have not undergone at-
mospheric transformation and ‘aged’ DEPs particles such
as those used in the current study, which we were unable
to analyze during this study. However a study examining
the impact of freshly generated DEPs on epithelial cells
followed by a study examining the effect of those same
particles as they age with time, would be an important
area for future exploration.
Secondly, we did not find any upregulation of AR gene
expression, although induction of TGFα was observed.
This discrepancy may simply be due to differences in the
kinetics of AR expression in PBECs compared with the cell
line. Indeed, it is known that induction of EGFR ligands
mRNAs show different kinetic profiles, where AR and HB-
EGF gene expression are induced as an early response,
followed by a later response for TGF-α [28]. At the protein
level, there was augmented AR release in response
to DEPs, but blockade of the EGFR with neutralizing
antibodies caused accumulation of TGF-α in the culture
medium, rather than AR. Although the preferential accu-
mulation of TGFα suggested that it may be the major lig-
and responsible for IL-8 release, experiments using specific
neutralising antibodies directed against TGFα, AR and
HB-EGF indicated that they each made a contribution to
the overall response to DEPs. This combinatorial effect
may again reflect the ability of EGFR ligands to auto- and
cross-induce their expression in a temporal fashion. Con-
sistent with the lack of effect of antioxidants, the ability of
the ligand antibodies to completely suppress DEPs-induced
IL-8 release suggested that ligand independent activation
of the EGFR did not contribute significantly to the re-
sponses that we observed.
Previous studies using A549 cells have suggested that a
variety of environmental particles (ambient particulates
and inorganic particles) can elicit IL-8 production by these
cells. Use of a panel of ligands known to inhibit scavenger
receptors selectively blocked responses to these particles,
although the epithelial scavenger-type receptor was dis-
tinct from the heparin-insensitive acetylated-LDL receptor
[29]. More recently, studies with ambient particles have
suggested that normal human bronchial epithelial cells
recognize coarse and fine PM through toll-like receptor 2(TLR2) [30]. The authors suggested that degradation
products of bacteria are preferentially attached to coarse
pollution particles, and that bacteria themselves, dead or
alive are collected as components of coarse more than fine
PM. Although we collected fresh DEPs and allowed them
to age, they were not collected under sterile conditions.
Nonetheless, it seems unlikely that microbial contamin-
ation contributes to the responses that we observed since
we found that carbon black failed to elicit IL-8 release.
Thus it seems more likely that non-volatile combustion
products of diesel on the surface of the DEPs were respon-
sible for the effect.
These studies indicate a direct effect of DEPs on EGFR
ligand expression in primary bronchial epithelial cells.
EGFR ligands are involved in a number of effects that
could also potentially lead to the effects seen in chronic
asthma. TGF-α is associated with mucin hypersecretion
and pulmonary fibrosis as well as branching morphogen-
esis during lung development [31-34]. Amphiregulin (AR)
is an epidermal growth factor (EGF)-related peptide that
can bind to heparin and operates exclusively through the
EGFR. Studies have shown that this peptide is expressed
in PBEC [13,35]. Increased levels of this growth factor are
associated with malignancy in the breast [36]. HB-EGF,
another EGFR ligand, has been shown to mediate mucin
transcription [37] and fibroblast proliferation [38]. This
growth factor has been shown to be upregulated by van-
adium, through an oxidant dependent mechanism, as well
as cigarette smoke extract [39]. One of the limitations in
our study is that we did not fully explore the dynamic rela-
tionship between the antibodies utilized and the ligands
and receptors being explored. Future work should explore
the specificity, dose response relationship as well as the
kinetics of each of the antibodies utilized in this study to
better elucidate the underlying mechanisms as well as spe-
cificity of each of the antibodies. Further exploration
should also be focused on studying the effect of knock
down of specific ligands.
In conclusion, the epithelial IL-8 response to DEPs
occurs through the EGFR via shedding and involve-
ment of multiple autocrine EGFR ligands. The ability
of DEPs to induce expression and release of ligands
for the EGFR suggests that they may have other
direct effects on epithelial function such as induction
of proliferation or differentiation linked to mucus
production.
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